A University of Missouri-Kansas City researcher says a fluid made from soybean oil, egg lecithin and egg yolk revived mice that had been drained to clinical death, with a survival rate near 100%. Dr. Cuthbert Simpkins, a surgery professor and founder of Vivacelle Bio, calls it VBI-1 and says the nanoparticle technology avoids the reperfusion injury he links to brain damage when blood is reinfused. His earlier invention, VBI-S, is still awaiting FDA approval for septic shock.
The excitement comes with a serious asterisk. Dr. Richard Galbraith, director of transfusion medicine at University Health KC, calls the results interesting and hopeful but says a completely synthetic blood replacement is extremely unlikely. Blood serves too many purposes, and hospitals still depend on donations for cancer treatment, chronic disease and trauma, with University Health KC alone using at least 500 units a day. Simpkins says human clinical trials could take one to two years, with FDA approval and a market release targeted for 2031.
For Suncoast communities, the story lands on familiar ground. Blood shortages have repeatedly hit critically low levels since 2020, and hurricane season has a way of stressing every part of our supply chain. Whether VBI-1 is a decade away or never arrives, the local need is immediate. Would you trust a blood substitute made from egg and soybean oil, or are you sticking with the real thing? Let us know.
